Matthew Keiser

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Replacement Therapy

Multiple Sclerosis

Top Venues

Patient preference and adherence

JMIR human factors

Expert opinion on drug delivery

This page only lists publications with an associated author ORCID identifier.

Publications

José I. Labarta, Paul Dimitri, Matthew Keiser, Ekaterina Koledova, Octavio Rivera Romero
Evaluating the Usefulness and Ease of Use of a Next-Generation-Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals' Perceptions. JMIR human factors 10 (2023)
Yu-Ting Lin, Tamara Will, Charlotte Wickham, Petra Boeree, Dominic Jack, Matthew Keiser
Evolution of the RebiSmart ® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis. Patient preference and adherence 17 (2023)
Francesco Piras, Lilian Arnaud, Eric Henninger, Matthew Keiser, Andrea Seitzinger, Dominic Jack, Quentin Le Masne
Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years. Expert opinion on drug delivery (2023)